Your session is about to expire
What is Miglitol
Approved as Treatment by the FDA
Miglitol, also known as Glyset, is approved by the FDA for 2 uses including Type 2 Diabetes Mellitus and Type 2 Diabetes .Effectiveness
When to interrupt dosage
The endorsed dose of Miglitol is subject to the identified condition, including Type 2 Diabetes, Physical Activity and Diet. The amount of dosage fluctuates, as outlined by the course of delivery (e.g. Tablet, coated - Oral or Oral) detailed in the table below.Warnings
Miglitol has nine contraindications, and its use should be abstained from when dealing with any of the conditions stated in the subsequent table.Miglitol ContraindicationsMiglitol Novel Uses: Which Conditions Have a Clinical Trial Featuring Miglitol?
196 active trials are currently assessing the potential of Miglitol to improve Diet, Type 2 Diabetes and Physical Activity outcomes.Miglitol Reviews: What are patients saying about Miglitol?
Patient Q&A Section about miglitol
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.What is miglitol used for?
"Miglitol is used to lower high blood sugar levels that are caused by type 2 diabetes."
When should miglitol be taken?
"Miglitol comes in the form of a tablet that is meant to be taken orally. The recommended dosage is three times a day, with the first dose being taken during the first bite of a meal. It is important to follow the directions on the prescription label carefully and to ask for clarification from a doctor or pharmacist if anything is unclear."
What are the side effects of miglitol?
"Diarrhea, gas, upset stomach, stomach or abdominal pain, skin rash, or iron deficiency anemia are common side effects in the first few weeks of treatment as the body adjusts to this medication but these side effects usually improve with time."
What type of medication is miglitol?
"Miglitol works by delaying the digestion of carbohydrates. It inhibits the breakdown of complex carbohydrates into glucose, which helps improve glycemic control."